FinanceMoneycontrol
Hold Ajanta Pharma; target of Rs 3260: ICICI Securities
in5points
ICICI Securities recommended a hold rating on Ajanta Pharma with a target price of Rs 3260.
The research report was dated July 31, 2026.
ICICI Securities recommended a hold rating on Ajanta Pharma with a target price of Rs 3260.
The research report was dated July 31, 2026.
